“We recognize that achieving clinical trials that include diverse populations presents an ongoing challenge,” the PhRMA trade association says in a recent addition to its white paper on Principles on […]
The U.S. Food and Drug Administration (FDA) drug and biological product centers intend, to the extent appropriate and permitted by law, to publicly post their reviews of the scientific data […]
Exciting news about potential COVID-19 vaccines in recent days serves as a reminder of how admirably the clinical trial industry has risen to the challenge of battling a worldwide health […]
It’s looking more and more like the so-called “COVID catalyst” inspiring faster adoption of technology and virtual components in clinical trials is the real deal. The latest evidence: a new […]
Demonstrating the increasingly international flavor of clinical trials, a new report from the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) found nearly two-thirds of participants […]